Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286879 · ClinicalTrials.gov registry record · NA
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
A NA study of Opioid Use Disorder and Substance Use, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 3
- Study locations
NCT05286879: Active NA study of Opioid Use Disorder and Substance Use, sponsored by Yale University.
NCT05286879 is a NA study of Opioid Use Disorder and Substance Use that is active but no longer recruiting, run by Yale University. The registered enrollment target is 600 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05286879, a NA study of Opioid Use Disorder and Substance Use, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI treatment, and opioid use disorder (OUD) prevention and treatment, medication for opioid use disorder (MOUD) service cascades of care.
Primary Outcome
Time to post-release initiation of ART for persons living with HIV. Measured by self-reported initiation within 6-months. ART initiation will be measured as the date of self-reported initiation within the 6-month intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigator
- BEHAVIORAL Mobile Health Unit
Study Locations (3)
Texas
- UT Southwestern - Dallas
- Texas Christian University - Fort Worth
Connecticut
- Yale School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT05286879 still lists
NCT05286879 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (87% lower).
The record links to 6 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigator is the first listed.
NCT05286879 reports a single indexed study location in Texas, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05286879 about?
NCT05286879 is a clinical study titled "Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations". This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI treatment, and opio...
What is the current status of trial NCT05286879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2022-03-31. Estimated completion is 2025-12-31.
What conditions does trial NCT05286879 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use, Substance Abuse, Infectious Disease, Stimulant Use Disorder.
What interventions are being tested in trial NCT05286879?
The interventions under investigation include: Patient Navigator (BEHAVIORAL), Mobile Health Unit (BEHAVIORAL).
Who is sponsoring clinical trial NCT05286879?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05286879 being conducted?
This trial has 3 study locations across Connecticut, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05286879's enrollment target sits among peer trials
600 27th of 257 higher than 228 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI